Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Cyclacel> ?p ?o. }
Showing items 1 to 62 of
62
with 100 items per page.
- Cyclacel abstract "Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Dundee, Scotland and Short Hills, New Jersey developing cancer drugs and treatments. Cyclacel was founded in 1996 by Professor David Lane, Merlin Ventures and Cancer Research Campaign Technology with the University of Dundee and the University of Glasgow. Major shareholders include Goldman Sachs Group, Tang Capital Management, Redmile Group and Ayer Capital Management.The firm is developing "mechanism-targeted drugs" to help in the fight of cancer, and other serious illness, such as diabetes and HIV.".
- Cyclacel foundingYear "1997".
- Cyclacel industry Biotechnology.
- Cyclacel keyPerson David_Lane_(oncologist).
- Cyclacel keyPerson Spiro_Rombotis.
- Cyclacel location Berkeley_Heights,_New_Jersey.
- Cyclacel netIncome "1.97E7".
- Cyclacel numberOfEmployees "18".
- Cyclacel product Aurora_kinase.
- Cyclacel product Sapacitabine.
- Cyclacel product Seliciclib.
- Cyclacel wikiPageExternalLink www.cyclacel.com.
- Cyclacel wikiPageID "4768936".
- Cyclacel wikiPageRevisionID "583763470".
- Cyclacel companyLogo File:Cyclacel.png.
- Cyclacel companyName "Cyclacel Pharmaceuticals, Inc.".
- Cyclacel companyType "Public".
- Cyclacel foundation "1997".
- Cyclacel hasPhotoCollection Cyclacel.
- Cyclacel homepage www.cyclacel.com.
- Cyclacel industry Biotechnology.
- Cyclacel keyPeople "David P. Lane, Founder".
- Cyclacel keyPeople "Spiro Rombotis, CEO".
- Cyclacel location "Berkeley Heights, New Jersey, U.S.".
- Cyclacel netIncome "US$ 19.7 million".
- Cyclacel numEmployees "18".
- Cyclacel products "Aurora kinase inhibitors".
- Cyclacel products "Sapacitabine ,".
- Cyclacel products "Seliciclib ,".
- Cyclacel wordnet_type synset-company-noun-1.
- Cyclacel subject Category:1996_establishments_in_Scotland.
- Cyclacel subject Category:Companies_based_in_Dundee.
- Cyclacel subject Category:Companies_established_in_1996.
- Cyclacel subject Category:Pharmaceutical_companies_of_Scotland.
- Cyclacel type Abstraction100002137.
- Cyclacel type Company108058098.
- Cyclacel type DrugCompany108002578.
- Cyclacel type Group100031264.
- Cyclacel type Institution108053576.
- Cyclacel type Organization108008335.
- Cyclacel type PharmaceuticalCompaniesOfTheUnitedKingdom.
- Cyclacel type SocialGroup107950920.
- Cyclacel type YagoLegalActor.
- Cyclacel type YagoLegalActorGeo.
- Cyclacel type YagoPermanentlyLocatedEntity.
- Cyclacel type Agent.
- Cyclacel type Company.
- Cyclacel type Organisation.
- Cyclacel type Organization.
- Cyclacel type Agent.
- Cyclacel type SocialPerson.
- Cyclacel type Thing.
- Cyclacel comment "Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Dundee, Scotland and Short Hills, New Jersey developing cancer drugs and treatments. Cyclacel was founded in 1996 by Professor David Lane, Merlin Ventures and Cancer Research Campaign Technology with the University of Dundee and the University of Glasgow.".
- Cyclacel label "Cyclacel".
- Cyclacel sameAs m.0cm9s9.
- Cyclacel sameAs Q5198104.
- Cyclacel sameAs Q5198104.
- Cyclacel sameAs Cyclacel.
- Cyclacel wasDerivedFrom Cyclacel?oldid=583763470.
- Cyclacel homepage www.cyclacel.com.
- Cyclacel isPrimaryTopicOf Cyclacel.
- Cyclacel name "Cyclacel Pharmaceuticals, Inc.".
